Canyon Labs announced the strategic acquisition of iuvo BioScience’s laboratory services and scientific consulting divisions, according to a press release.
The acquisition “positions Canyon Labs to deliver comprehensive end-to-end solutions in pharmaceutical and medical device development and strengthens iuvo BioScience’s focus on transformative ophthalmic clinical development contract research,” the release said.
Iuvo BioScience will retain its clinical research team and leadership structure.
“This transaction marks a defining moment for iuvo,” Ben Burton,